SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-016716
Filing Date
2022-04-29
Accepted
2022-04-29 06:05:15
Documents
6
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20003245x1_def14a.htm DEF 14A 892046
2 logo_pliant.jpg GRAPHIC 33501
3 logo_pliantx1.jpg GRAPHIC 44873
4 ny20003245x1-pc_1.jpg GRAPHIC 558900
5 ny20003245x1-pc_2.jpg GRAPHIC 490361
6 sig_mouimette.jpg GRAPHIC 18498
  Complete submission text file 0001140361-22-016716.txt   2470384
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39303 | Film No.: 22869831
SIC: 2834 Pharmaceutical Preparations